Junning Ma | Clinical Nano Science | Editorial Board Member

Editorial Board Member

Junning Ma
Zhejiang University

Junning Ma
Affiliation Zhejiang University
Country China
Citations 314
Works 4
Subject Area Clinical Nano Science
Event International Invention Awards
ORCID 0000-0003-3499-8246

Junning Ma is identified in the supplied profile as a researcher affiliated with Zhejiang University, China, with a stated research area of Clinical Nano Science. The profile reports four research works and 314 citations, although these bibliometric figures require independent verification against the relevant database. The researcher’s ORCID identifier provides a persistent reference for checking scholarly identity and associated research outputs. This article summarizes the available profile information and its relevance to academic research and the International Invention Awards, without attributing unverified publications or discoveries to the researcher. [1]

Abstract

This article presents a researcher profile for Junning Ma, identified in the supplied information as being affiliated with Zhejiang University, China, and working in the area of Clinical Nano Science. The available profile reports four research works and 314 citations, figures that require verification against authoritative bibliographic records. An ORCID identifier is included to facilitate researcher identification and discovery of associated scholarly outputs. The article reviews the research profile, potential contributions, publication information, scholarly impact, and relevance to the International Invention Awards. A comprehensive evaluation requires verified publications, documented research achievements, and evidence demonstrating originality, scientific significance, and practical impact.

Keywords

Junning Ma; Zhejiang University; Clinical Nano Science; nanoscience; nanotechnology; clinical research; scholarly publications; research impact; ORCID; academic recognition; International Invention Awards.

Introduction

Clinical nanoscience combines nanoscale materials and technologies with biomedical research to investigate potential applications in diagnosis, imaging, treatment, and healthcare. Its interdisciplinary nature requires evaluation of experimental evidence, methodological rigor, and the relevance of findings to clinical or scientific challenges. The supplied information identifies Junning Ma with Zhejiang University and Clinical Nano Science. Establishing a reliable research biography requires confirmation of the researcher’s identity, institutional affiliation, publications, and specific contributions using authoritative sources. Persistent researcher identifiers and bibliographic databases are useful tools for supporting this verification process. [1]

Research Profile

The supplied profile identifies Junning Ma as affiliated with Zhejiang University, China, and reports four research works and 314 citations. These figures provide preliminary bibliometric information but do not independently establish publication quality, authorship accuracy, or the significance of individual contributions. The supplied ORCID identifier can be used to investigate the researcher’s registered scholarly activities. Verification should include matching author names, institutional affiliations, publication metadata, and persistent identifiers to ensure that records are correctly attributed and that the profile remains accurate. [1] [2]

Research Contributions

Research contributions in clinical nanoscience may include developing nanomaterials, improving biomedical measurement techniques, investigating nanoscale interactions, or exploring technologies for clinical applications. The value of a contribution depends on the originality of the research question, the reliability of its methods, and the reproducibility and significance of its results. The supplied information does not identify specific publications, inventions, or experimental findings attributable to Junning Ma. Individual contributions should therefore be documented using original research papers, verified project records, and other appropriate supporting evidence before definitive claims are made.

Publications

The profile information reports four research works, but individual publication titles, journals, publication dates, DOI identifiers, and author positions have not been supplied. These details should be obtained from verified scholarly records rather than generated from incomplete information. Scopus and other bibliographic databases can support the identification of relevant publications and citation records. Each publication should be checked for correct authorship, institutional affiliation, and DOI resolution before inclusion in a formal academic biography or award evaluation. [2]

Research Impact

The reported citation count of 314 may provide an initial indication of scholarly visibility, subject to verification of the database and researcher identity. Citation metrics vary according to database coverage, publication age, disciplinary conventions, and collaborative practices. A balanced impact assessment should also consider the quality of the research, independent use of findings, reproducibility, and demonstrable scientific or clinical outcomes. The h-index is not available in the supplied information and should not be inferred from the reported citation count or number of research works. [2]

Award Suitability

The International Invention Awards is the recognition event specified for this profile. Assessment for an award should consider the applicable eligibility requirements, originality, documented individual contributions, scientific or technical merit, and evidence of impact. The supplied research profile can provide preliminary background information but is not sufficient on its own to establish eligibility or selection. A comprehensive assessment should use a verified curriculum vitae, relevant publications, supporting evidence of research or inventions, and the official award criteria published by the organizers. [3]

Conclusion

The supplied information presents Junning Ma as a researcher affiliated with Zhejiang University, China, in the subject area of Clinical Nano Science. Four research works and 314 citations are reported, and an ORCID identifier is provided for further verification. The Scopus author ID, h-index, individual publication records, and specific research achievements remain unverified or unavailable. Confirmation against authoritative academic records is necessary before treating the profile as a complete, independently verified biography or using it as the basis for formal recognition.

References

  1. ORCID. (n.d.). ORCID: Connecting Research and Researchers. ORCID
    https://orcid.org/0000-0003-3499-8246
  2. Journal article. (2019. ). Targeted Drug Delivery to Stroke via Chemotactic Recruitment of Nanoparticles Coated with Membrane of Engineered Neural Stem Cells.
    https://doi.org/10.1002/smll.201902011
  3. International Invention Awards. (2026.). Official website.
    https://inventionawards.org/

Thiago Caon | Biopharmacy | Pinnacle Research Achievement Award

Prof. Thiago Caon | Biopharmacy | Pinnacle Research Achievement Award

Federal University of Santa Catarina, Brazil

Prof. Thiago Caon holds a PhD in Pharmacy from the Federal University of Santa Catarina (UFSC, 2014), with a sandwich doctorate at Monash University, Australia, under the supervision of Joseph A. Nicolazzo, and a Master’s degree in Biotechnology (UFSC, 2009), in addition to undergraduate degrees in Pharmacy (UFSC, 2006) and Business Administration (UDESC, 2011). His doctoral research focused on the development of pharmaceutic strategies to improve the biopharmaceutical characteristics and intestinal absorption of saquinavir mesylate, aiming at cost-effective formulations suitable for public health systems, while his master’s work standardized ex vivo Franz diffusion cell models for drug permeability studies across skin and mucosal tissues. He completed a postdoctoral fellowship at UFSC (2014–2015) in pharmaceutical quality assurance and control, supported by CAPES, and has extensive expertise in biopharmaceutics and pharmaceutical technology, particularly in molecular transport across biological membranes, alternative drug administration routes (skin, buccal, mucosal, and sublingual), and the development of nanotechnology-based delivery systems, polymeric films, and hydrogels. Prof. Caon has undertaken complementary research training at UFRGS and Monash University and participated in national initiatives such as the restructuring of the Brazilian Phytotherapy Network in collaboration with the Ministry of Health. Since 2015, he has been a faculty member in the Department of Pharmaceutical Sciences at UFSC, where he is a permanent professor in the Graduate Program in Pharmacy and has served as research coordinator since 2021. He was a key contributor to the creation of the Junior Pharmacy Enterprise (EJIFAR) and is actively involved in innovation and extension projects with biotechnology and pharmaceutical companies, resulting in products on the market and multiple patent applications. His scientific output includes more than 80 peer-reviewed articles, several book chapters, five patent applications, and extensive activity as an ad-hoc reviewer for international journals, reflecting a strong academic profile integrated with innovation, entrepreneurship, and public health impact.

Citation Metrics (Scopus)

2500
2000
1500
1000
100
0

Citations
2044

Documents
87

h-index
25

Citations

Documents

h-index

View Scopus Profile

Featured Publications

 

Mr. Sébastien Tessier | Aerosolized Medication | Best Researcher Award

Mr. Sébastien Tessier | Aerosolized Medication | Best Researcher Award

Winnipeg Regional health Authority, Canada.

Sébastien Tessier is a distinguished healthcare leader, respiratory therapy expert, and academic with extensive experience in clinical innovation, leadership, and education. He has played a pivotal role in advancing healthcare services, particularly in respiratory therapy and interprofessional collaboration. With a strong background in leadership and healthcare innovation, he currently serves as Director of Clinical Services – Medicine, Family Medicine, and Rehab at the Winnipeg Regional Health Authority. Sébastien is fluent in both English and French and is actively engaged in research, teaching, and professional organizations that shape the future of respiratory therapy and healthcare management.

Profile

Orcid

Education 🎓

Mr. Sébastien Tessier is a dedicated professional with a strong academic background in business leadership and respiratory therapy. He earned his Master of Business Administration (Leadership) from Dalhousie University in Halifax, NS, between 2019 and 2021. Prior to this, he completed a Bachelor of Respiratory Therapy at the University of Manitoba, Winnipeg, MB, in 2014-2015. His educational journey began at La Cité Collégiale in Ottawa, ON, where he obtained an Advanced Diploma of Respiratory Therapy from 2009 to 2012. With a unique blend of healthcare expertise and leadership training, Mr. Tessier is well-equipped to contribute effectively to both clinical and managerial roles in the healthcare sector.

Professional Experience 👩‍🏫

Mr. Sébastien Tessier is a healthcare leader with extensive experience in clinical services, innovation, and education. Currently serving as Director of Clinical Service (Medicine, Family Medicine, Rehab) at the Winnipeg Regional Health Authority (2024–Present), he leads healthcare transformation across multiple hospitals and health centers. Previously, he was a Leadership Resident at WRHA (2023–2024), working closely with the CEO on strategic health projects. As Director of Innovation at Centre de Santé – St. Boniface (2022–2023), he spearheaded initiatives to enhance patient care. He is also a Sessional Instructor at the University of Manitoba (2022–Present) and has held key roles in clinical education and healthcare technology with Masimo Canada, Zoll Medical, and Shared Health Manitoba. With expertise in respiratory therapy, neonatal and pediatric critical care, and healthcare innovation, he continues to shape the future of patient care and medical education.

Research Interests 🔬

Sébastien Tessier’s research focuses on respiratory therapy advancements, healthcare innovation, and interprofessional collaboration. His work includes:

Optimization of aerosol drug delivery in pediatric care

Neonatal and pediatric respiratory care advancements

Healthcare leadership and policy innovation

Interprofessional education in respiratory therapy

Awards & Honors 🏆

Children’s Hospital Research Institute of Manitoba – Biology of Breathing Catalyst Grant (2020)

Louis-Phillipe Belisle Scholarship Award for Graduate Studies (2020)

Fellowship of the Canadian Society of Respiratory Therapists (FCSRT) (2020)

Publications 📚

Optimization of Albuterol Delivery via Anesthesia Bag in Pediatric Critical Care (Tessier, S., et al., 2025) – Pharmaceutics

Investigates innovative methods for optimizing albuterol delivery in pediatric critical care.

Enhances drug administration efficiency and patient outcomes.

Optimal Delivery of Aerosolized Medication to Mechanically Ventilated Pediatric and Neonatal Patients: A Scoping Review (Chartrand, L., Tessier, S., et al., 2022) – Canadian Journal of Respiratory Therapy

Reviews best practices for aerosolized medication administration in neonatal and pediatric critical care.

Provides evidence-based recommendations for improving respiratory therapy techniques.

 

 

Dr. Ana Filipa Pires | Drug Delivery Systems | Best Researcher Award

Dr. Ana Filipa Pires | Drug Delivery Systems | Best Researcher Award

Institute of Telecommunications, Portugal.

Ana Filipa Soares Pires is a Junior Researcher specializing in biomaterials and bioelectronic devices at Instituto de Telecomunicações, Instituto Superior Técnico. Her research focuses on creating systems that respond to stimuli like light, electricity, and magnetism to guide cell behavior for tissue regeneration. She is particularly interested in drug delivery systems, such as liposomes, nanoparticles, and hydrogels, and has made groundbreaking contributions to bioelectronics and personalized medicine. Ana's work on biodegradable LEDs for real-time monitoring of anticancer drugs has propelled innovations in precision medicine and tissue engineering.

Profile

Scopus

Orcid

Education 🎓

Ana Filipa Soares Pires holds a Ph.D. in Radiation Biology and Biophysics, where she specialized in biomaterials and bioelectronics. Her educational background also includes Master's Fellowships in Pharmacokinetic Analysis (PEstOE/EEI/LA0008/2014), focusing on the pharmacokinetics of nanostructured films, and in Textile Electrode Design (2014), where she innovated designs using cotton and silk electrodes to collect electrical signals from living tissue. Her education laid the foundation for her pioneering work in bioelectronics, tissue engineering, and drug delivery systems.

Experience  💼

Ana's research experience spans multiple interdisciplinary projects, including the development of drug delivery systems, tissue scaffolds, and biosensors. She has collaborated with leading researchers from institutions such as IFSCAR (Brazil) and Synchrotron Facilities (Denmark), and her work is published in prestigious journals like European Polymer Journal and Fungal Biology. As a guest editor, Ana has also contributed to the scientific community by editing special issues and reviewing for top-tier journals.

Research Interests 🔬

Biomaterials & Bioelectronics: Developing biodegradable LEDs for real-time monitoring of anticancer drugs.

Drug Delivery Systems: Improving the precision and safety of therapeutic treatments using liposomes, nanoparticles, and hydrogels.

Tissue Engineering: Engineering conducting scaffolds for neural tissue regeneration.

Molecular Interactions: Exploring the interaction between catechins and cellular membranes for their antioxidant effects.

Awards and Honors 🏆

Ana has been recognized for her exceptional contributions to bioelectronics and biomaterials. Some notable projects she has worked on include:

European Innovation Council, EIC PathFinder (2022-2025)

Co-PI for "Magnetic field-assisted MSCs-based therapies" (La Caixa Foundation, 2022)

Master Fellow in Pharmacokinetic Analysis of Nanostructured Films

Selected Publications 📚

Heparinized Acellular Hydrogels for Magnetically Induced Wound Healing Applications

Authors: Pires, F., Silva, J.C., Ferreira, F.C., Portugal, C.A.M.
Journal: ACS Applied Materials and Interfaces
Year: 2024, Volume: 16(8), Pages: 9908–9924
Citations: 4

Indium-gallium-zinc-oxide Based Semitransparent Electrodes on Flexible Substrates for Biodegradable Electronics

Authors: Pompilio, M., Gharehbagh, J.S., Krik, S., Ciocca, M., Cacialli, F.
Conference: 6th IEEE International Flexible Electronics Technology Conference, IFETC 2024 - Proceedings
Year: 2024

Magnetic-Responsive Liposomal Hydrogel Membranes for Controlled Release of Small Bioactive Molecules—An Insight into the Release Kinetics

Authors: Pereira, L., Ferreira, F.C., Pires, F., Portugal, C.A.M.
Journal: Membranes
Year: 2023, Volume: 13(7), Article: 674
Citations: 5

The Impact of Blue Light in Monolayers Representing Tumorigenic and Nontumorigenic Cell Membranes Containing Epigallocatechin-3-gallate

Authors: Pires, F., Magalhães-Mota, G., Geraldo, V.P.N., Oliveira, O.N., Raposo, M.
Journal: Colloids and Surfaces B: Biointerfaces
Year: 2020, Volume: 193, Article: 111129
Citations: 19

Effect of Epigallocatechin-3-gallate on DMPC Oxidation Revealed by Infrared Spectroscopy

Authors: Pires, F., Rodrigues, B., Magalhães-Mota, G., Ribeiro, P.A., Raposo, M.
Conference: Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture)
Year: 2020